- Headquarters
- Seattle, Washington
- Employees
- 201–500
- Founded
- 2019
- Business Model
- B2B
- Website
- umojabiopharma.com
- Total Funding
- $363.0M
- Last Round
- $100.0M Series CJan 2025
About
Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account